Mindera Health

Mindera HealthTM is commercializing scalable extraction technology and data analysis to report a patients individual transcriptomic data. Minderas technology creates Dermal IntelligenceTM, actionable information for payers, providers and patients. The companys flagship test, Mind.Px, uses both a dermal biomarker patch and Machine Learning to determine a patients receptivity to very expensive psoriasis biologics. This information is valuable to payers, who can save thousands of dollars per biologic patient using Mind.Px at the outset of prescription. Mind.Px is the first test in a large planned product pipeline, including psoriatic arthritis and eczema biologic receptivity

Mindera health operates in the Biotechnology industry.

Mindera health's revenue is 1m - 10m

Mindera health has 11 - 50 employees.